Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma. [electronic resource] by
- Mai, E K
- Bertsch, U
- Dürig, J
- Kunz, C
- Haenel, M
- Blau, I W
- Munder, M
- Jauch, A
- Schurich, B
- Hielscher, T
- Merz, M
- Huegle-Doerr, B
- Seckinger, A
- Hose, D
- Hillengass, J
- Raab, M S
- Neben, K
- Lindemann, H-W
- Zeis, M
- Gerecke, C
- Schmidt-Wolf, I G H
- Weisel, K
- Scheid, C
- Salwender, H
- Goldschmidt, H
Producer: 20151105
In:
Leukemia vol. 29
Availability: No items available.
|